The CenterWatch Weekly, March 27, 2017
New data mapping software zeroes in on anomalies, trends
With thousands of data points collected in nearly every clinical trial, tech companies have been working to develop new ways to help teams sort out critical information. Recently, CluePoints announced the launch of Patient Profiles, a highly configurable platform that prioritizes atypical data, in an effort to help teams focus on at-risk study participants.
Industry reacts to proposed regulatory fee increase
President Trump’s proposed budget would require drug and device makers to pay more than double the current fees for regulatory approval, a concern that has many in the industry asking for more detail. The proposed budget posits the fee increases would improve the speed of regulatory approval, but specifics for how that outcome would be achieved have yet to be provided. The suggested budget also cuts nearly $6 billion from the NIH, which would greatly impact medical research funding.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information